Trials / Completed
CompletedNCT00880737
Prognostic Value of Computed Tomography (CT) Scan in Hemodynamically Stable Patients With Acute Symptomatic Pulmonary Embolism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 850 (estimated)
- Sponsor
- Carlos III Health Institute · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of the PROTECT study are: * To assess the role of CT pulmonary angiography in the risk stratification of hemodynamically stable patients with acute symptomatic pulmonary embolism (PE). * To assess the role of transthoracic echocardiography in the risk stratification of hemodynamically stable patients with acute symptomatic PE. * To assess the role of 2 biomarkers (troponin and brain natriuretic peptide) in the risk stratification of hemodynamically stable patients with acute symptomatic PE. * To assess the role of the Pulmonary Embolism Severity Index (PESI) in the risk stratification of hemodynamically stable patients with acute symptomatic PE. * To assess the combined role of CT pulmonary angiography, transthoracic echocardiography, PESI, troponin I and brain natriuretic peptide in the risk stratification of hemodynamically stable patients with acute symptomatic PE.
Conditions
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2011-06-01
- First posted
- 2009-04-14
- Last updated
- 2011-06-15
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00880737. Inclusion in this directory is not an endorsement.